XORTX Therapeutics Inc.XRTX
Price (close)
$1.72
Market cap
—
P/E
—
Revenue (FY)
—
Net income
-$1.7M
Dividend yield
—
1-year total return
-60.0%
Net margin
—
Revenue growth
—
Debt / equity
—
What XORTX Therapeutics Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Net income | — | -$629,576 | -$1.3M | -$1.7M |
More on XRTX.
- XORTX Therapeutics Inc. summary
- XORTX Therapeutics Inc. financial statements
- XORTX Therapeutics Inc. key metrics
- XORTX Therapeutics Inc. health scores and style box
- XORTX Therapeutics Inc. earnings
- XORTX Therapeutics Inc. dividends
- XORTX Therapeutics Inc. valuation
- XORTX Therapeutics Inc. ownership and insiders
- XORTX Therapeutics Inc. peers
Figures from XORTX Therapeutics Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.